BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Chubb
UBS
Cerilliant
Healthtrust
Federal Trade Commission
QuintilesIMS
Fuji
Johnson and Johnson
Mallinckrodt

Generated: January 22, 2018

DrugPatentWatch Database Preview

Cisatracurium besylate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cisatracurium besylate and what is the scope of cisatracurium besylate freedom to operate?

Cisatracurium besylate
is the generic ingredient in four branded drugs marketed by Accord Hlthcare, Fresenius Kabi Usa, Jiangsu Hengrui Med, Sandoz Inc, and Abbvie, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for cisatracurium besylate. Four suppliers are listed for this compound.
Summary for cisatracurium besylate
Pharmacology for cisatracurium besylate

US Patents and Regulatory Information for cisatracurium besylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jiangsu Hengrui Med CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate preservative free INJECTABLE;INJECTION 204960-002 Sep 19, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 200154-001 Feb 3, 2012 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Accord Hlthcare CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 205872-001 Jun 16, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Jiangsu Hengrui Med CISATRACURIUM BESYLATE cisatracurium besylate INJECTABLE;INJECTION 209334-001 Aug 30, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbvie NIMBEX PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 020551-002 Dec 15, 1995 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Jiangsu Hengrui Med CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 204960-001 Jan 27, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc CISATRACURIUM BESYLATE cisatracurium besylate INJECTABLE;INJECTION 200159-001 Feb 3, 2012 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Accord Hlthcare CISATRACURIUM BESYLATE cisatracurium besylate INJECTABLE;INJECTION 205873-001 Jun 16, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbvie NIMBEX PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 020551-003 Dec 15, 1995 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 203182-002 Feb 26, 2015 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for cisatracurium besylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie NIMBEX cisatracurium besylate INJECTABLE;INJECTION 020551-001 Dec 15, 1995 ➤ Subscribe ➤ Subscribe
Abbvie NIMBEX PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 020551-002 Dec 15, 1995 ➤ Subscribe ➤ Subscribe
Abbvie NIMBEX PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 020551-002 Dec 15, 1995 ➤ Subscribe ➤ Subscribe
Abbvie NIMBEX cisatracurium besylate INJECTABLE;INJECTION 020551-001 Dec 15, 1995 ➤ Subscribe ➤ Subscribe
Abbvie NIMBEX PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 020551-003 Dec 15, 1995 ➤ Subscribe ➤ Subscribe
Abbvie NIMBEX PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 020551-003 Dec 15, 1995 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Cipla
Federal Trade Commission
Queensland Health
Moodys
UBS
Medtronic
Deloitte
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot